Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Post by URLaughable3on Apr 19, 2018 1:22pm
153 Views
Post# 27912243

Consider adding shares before 24th

Consider adding shares before 24th Im not saying it’s going to pop. I just believe when ppl see the revs from a quickly expanding NHS and what I’m sure is going to be a surprisingly good value in Vape Conessouire, there should be a solidified bottom and nothing but uptrend afterward. Currently 250M cap.. NHS could show numbers at 6-8% of that cap alone... you really think a 20 multiplier on NHS revs alone is a fair value for Sunniva? <br/>

Food for thought (Market Cap to projected Production):<br/>
Aph 1.8B cap production at 230k kg ($7.7k cap per kg produced) <br/>
acb  4.3B cap production at 283k kg ($15.2k per kg)<br/>
Weed 5.1B cap production at 784k kg (6.45k per kg)<br/>
SNN 250M cap production at 225k kg (1.1k per kg) <br/>

Seems like SNN is due for some serious attention at some point soon. Especially with their Cross boarder advantages, and already being temporarily licensed in effing Cali lol
<< Previous
Bullboard Posts
Next >>